Fortune Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,325
| Closed | -$651K | – | 97 |
|
|
2025
Q1 | $651K | Sell |
4,325
-7
| -0.2% | -$1.05K | 0.56% | 53 |
|
|
2024
Q4 | $800K | Hold |
4,332
| – | – | 0.73% | 42 |
|
|
2024
Q3 | $853K | Hold |
4,332
| – | – | 0.77% | 42 |
|
|
2024
Q2 | $895K | Hold |
4,332
| – | – | 0.55% | 60 |
|
|
2024
Q1 | $1.17M | Hold |
4,332
| – | – | 0.74% | 40 |
|
|
2023
Q4 | $1.02M | Buy |
4,332
+186
| +4% | +$44K | 0.72% | 46 |
|
|
2023
Q3 | $813K | Hold |
4,146
| – | – | 0.62% | 52 |
|
|
2023
Q2 | $872K | Buy |
+4,146
| New | +$872K | 0.65% | 49 |
|